Martin Fan

Martin Fan is an accomplished professional in the field of biotechnology and immunology, currently serving as an Equity Research Associate at Wedbush Securities since February 2023, focusing on sell-side equity research. Prior experience includes roles as Disease Area Manager and Analyst at Oncology Resource Group and Jounce Therapeutics, respectively, where responsibility encompassed competitive intelligence collection and oncology project leadership, including patent applications and regulatory contributions. Martin's academic background includes a Ph.D. in Immunology from Harvard University, complemented by a Bachelor's degree in Chemistry from Washington University in St. Louis, along with research and collaborative experiences across prestigious institutions such as Osaka University and Cold Spring Harbor Laboratory.